Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioredoxin like 1 pseudogene 1 (TXNL1P1) is classified as a pseudogene. Pseudogenes are DNA segments with high sequence homology to a functional gene, in this case *thioredoxin like 1*, but are rendered non-functional and incapable of producing a protein due to disabling mutations or loss of regulatory elements[1][4]. They do not serve the molecular or therapeutic functions of active protein-coding genes and are not considered receptors, enzymes, or therapeutic targets. Although in rare circumstances some pseudogenes may influence the expression of their parent gene at the RNA level, there is no evidence for such functional regulatory activity or disease association specific to TXNL1P1. Key Points: - TXNL1P1 is *not* a gene product, receptor, enzyme, or classic drug target. - It is a **non-functional pseudogene** by current genomic nomenclature standards[4]. - No drug interactions, disease associations, biological functions, or safety/biomarker considerations are established for this entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thioredoxin like 1 pseudogene 1 (TXNL1P1).